HydraFacial and Vesper Healthcare announced a definitive merger agreement at an enterprise value of $1.1 billion. HydraFacial and Vesper Healthcare will combine, after which HydraFacial will become a public company. WHO: HydraFacial has a 23-year history. The company's HydraFacial system offers an effective, experiential, noninvasive, and accessible skin treatment experience. HydraFacial's innovative signature treatment utilizes [...]The post HydraFacial and Vesper Announce Healthcare Merger at $1.1 Billion Valuation appeared first on BeautyMatter.
Vesper Medical is a Pennsylvania-based medical device company that develops minimally-invasive peripheral vascular products for the treatment of deep venous diseases.